5) Precisionlife has been using its AI-driven combinatorial analytics platform to find genetic drivers of GLP-1 efficacy so that they can predict and stratify strong and weak responders.
More info:
PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.
